Join the Loyalty Program for Discounts

23. Hope for Acute Myeloid Leukemia

Episode Summary

When people learn they or a loved one has cancer, one of their first questions is usually about survival. Fortunately, more people are now surviving many cancers that used to be death sentences. However, despite an increase in the ability to diagnose acute myeloid leukemia (AML) and a greater understanding of the disease process, improvements in patient outcomes have not paralleled the increases in basic scientific understanding. Fortunately, more and more studies are evaluating the potential benefits of using nutrients such as MK4 to help promote health in people with AML and other cancers, with excellent results in clinical trials.

Or, listen on your favorite app: iTunes (Apple Podcasts) | Spotify 

Key Takeaways To Tune In For

  • [01:11] What is Acute Myeloid Leukemia (AML)
  • [02:00] How does AML develop
  • [03:40] Why mortality rate from AML has not improved over the years
  • [08:10] Understanding how conventional medicine treats AML
  • [09:30] 20% of AML cases are caused by past cancer treatments
  • [11:10] Environmental toxins that are known to cause AML
  • [12:35] Symptoms of AML
  • [13:50] 3 general categories of AML treatment phases
  • [16:05] 20% to 40% of patients do not achieve remission with the standard chemotherapy
  • [17:55] All about maintenance therapy
  • [18:35] How successful is a conventional approach
  • [19:35] What can you do to lower the risks of AML

Resources talked about in this episode

Visit our social media for more information

Share This